The current valuation score of ATAI Life Sciences NV is 6.60, ranking 309 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.71, which is -32.92% below the recent high of -1.15 and -626.91% above the recent low of -12.46.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.